Dr. Abdelalim is a Principal Investigator at Sidra Medicine, where he leads the Laboratory of Pluripotent Stem Cell Disease Modeling. He earned his PhD in Medical Science from Shiga University of Medical Science in Japan. Subsequently, he undertook a postdoctoral fellowship and assumed the role of Assistant Professor at the same University. Before joining Sidra, he held the position of Senior Scientist at QBRI until February 2024. Notably, he established Qatar’s first pluripotent stem cell program focused to diabetes research. His team successfully generated multiple iPSC lines from healthy and diseased individuals and developed advanced protocols to enhance the differentiation of stem cells into pancreatic islets, insulin-target cells, and other cell types. He played a key role as Chair of the HSCI-QBRI Steering Committee Agreement, coordinating collaborative efforts between the HSCI and QBRI in stem cell and diabetes research. Also, Dr. Abdelalim serves on the editorial boards of “Stem Cells Translational Medicine” and “Stem Cells and Development”. He has authored over 75 peer-reviewed articles and has received numerous research grants and honors for his contributions to the field. Dr. Abdelalim also holds a joint appointment as Associate Professor at HBKU, where he teaches “Stem Cell Biology” and mentors graduate students.
